Stressors and rheumatoid arthritis: changes in stressors with advances in therapeutic agents
The significance of evaluations of stressors in rheumatoid arthritis (RA) patients was investigated from the perspective of holistic medicine. The subjects were RA patients treated in the rheumatology outpatient clinic. They included 30 patients from 1987, 30 from 2002, and 137 from 2009. To investi...
Gespeichert in:
Veröffentlicht in: | Rheumatology international 2013-04, Vol.33 (4), p.887-891 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 891 |
---|---|
container_issue | 4 |
container_start_page | 887 |
container_title | Rheumatology international |
container_volume | 33 |
creator | Otake, Tomoko Ashihara, Mutsumi Nishino, Jo Kato, Kenichi Fukaya, Shusaku Yoshida, Shunji |
description | The significance of evaluations of stressors in rheumatoid arthritis (RA) patients was investigated from the perspective of holistic medicine. The subjects were RA patients treated in the rheumatology outpatient clinic. They included 30 patients from 1987, 30 from 2002, and 137 from 2009. To investigate the specific causes of stress, the patients were asked the question, “What do you feel is your strongest stressor?” The same patients also underwent psychological testing and was examined the disease activity. Pain was the strongest stressor in RA patients in 1987, 2002, and 2009. However, the percentage of patients citing pain as their major stressor was decreasing with each year. CRP was significantly lower in 2009 than in 2002. CRP was also significantly lower in patients who used biologics than in patients who did not. In 2009, DAS28-CRP was significantly higher in patients whose largest stressor was pain than in patients whose largest stressor was another factor. In 2009, the values for both state anxiety and trait anxiety were significantly higher in patients who said that they had stressors than in those who said they did not. The strongest stressor in RA patients was pain. However, the percentage decreased over the years with lower disease activity from advances in therapeutic agents such as biologics. Meanwhile, stressors other than pain were the same or somewhat increased, and they were related to anxiety or depression. Understanding stressors in RA is thus important in treating RA patients. |
doi_str_mv | 10.1007/s00296-012-2457-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1322590644</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2933707511</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-883095b5f009708af00124e96b935807e38bf0392cfa472c4fcc31785d5d927b3</originalsourceid><addsrcrecordid>eNp1kE1LxDAURYMozjj6A9xIwXX05aNJ404Gv2DAhQouhJCm6bTitGOSKv57M3QUN27yCO-8e-EgdEzgjADI8wBAlcBAKKY8l1jsoCnhTGIi4HkXTYFIiov0TNBBCK-Q_kLAPppQWhAuFZ2il4foXQi9D5npqsw3bliZ2LdVZnxsfBvbcJHZxnRLF7K2y8Iv_tnGJjPVh-nsuIqN82bthtjazCxdF8Mh2qvNW3BH2zlDT9dXj_NbvLi_uZtfLrBlkkZcFAxUXuY1gJJQmDQJ5U6JUrG8AOlYUdbAFLW14ZJaXlvLiCzyKq8UlSWbodMxd-3798GFqF_7wXepUhNGaa5AcJ4oMlLW9yF4V-u1b1fGf2kCeuNTjz51atcbn1qkm5Nt8lCuXPV78SMwAXQEQlolSf5P9b-p35GLgHA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1322590644</pqid></control><display><type>article</type><title>Stressors and rheumatoid arthritis: changes in stressors with advances in therapeutic agents</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Otake, Tomoko ; Ashihara, Mutsumi ; Nishino, Jo ; Kato, Kenichi ; Fukaya, Shusaku ; Yoshida, Shunji</creator><creatorcontrib>Otake, Tomoko ; Ashihara, Mutsumi ; Nishino, Jo ; Kato, Kenichi ; Fukaya, Shusaku ; Yoshida, Shunji</creatorcontrib><description>The significance of evaluations of stressors in rheumatoid arthritis (RA) patients was investigated from the perspective of holistic medicine. The subjects were RA patients treated in the rheumatology outpatient clinic. They included 30 patients from 1987, 30 from 2002, and 137 from 2009. To investigate the specific causes of stress, the patients were asked the question, “What do you feel is your strongest stressor?” The same patients also underwent psychological testing and was examined the disease activity. Pain was the strongest stressor in RA patients in 1987, 2002, and 2009. However, the percentage of patients citing pain as their major stressor was decreasing with each year. CRP was significantly lower in 2009 than in 2002. CRP was also significantly lower in patients who used biologics than in patients who did not. In 2009, DAS28-CRP was significantly higher in patients whose largest stressor was pain than in patients whose largest stressor was another factor. In 2009, the values for both state anxiety and trait anxiety were significantly higher in patients who said that they had stressors than in those who said they did not. The strongest stressor in RA patients was pain. However, the percentage decreased over the years with lower disease activity from advances in therapeutic agents such as biologics. Meanwhile, stressors other than pain were the same or somewhat increased, and they were related to anxiety or depression. Understanding stressors in RA is thus important in treating RA patients.</description><identifier>ISSN: 0172-8172</identifier><identifier>EISSN: 1437-160X</identifier><identifier>DOI: 10.1007/s00296-012-2457-6</identifier><identifier>PMID: 22814792</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Adult ; Aged ; Antirheumatic Agents - therapeutic use ; Arthritis, Rheumatoid - drug therapy ; Arthritis, Rheumatoid - psychology ; Biological Products - therapeutic use ; Female ; Health Status ; Humans ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Original Article ; Pain - drug therapy ; Pain - psychology ; Pain Measurement ; Rheumatology ; Severity of Illness Index ; Stress, Psychological - psychology</subject><ispartof>Rheumatology international, 2013-04, Vol.33 (4), p.887-891</ispartof><rights>Springer-Verlag 2012</rights><rights>Springer-Verlag Berlin Heidelberg 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-883095b5f009708af00124e96b935807e38bf0392cfa472c4fcc31785d5d927b3</citedby><cites>FETCH-LOGICAL-c372t-883095b5f009708af00124e96b935807e38bf0392cfa472c4fcc31785d5d927b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00296-012-2457-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00296-012-2457-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22814792$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Otake, Tomoko</creatorcontrib><creatorcontrib>Ashihara, Mutsumi</creatorcontrib><creatorcontrib>Nishino, Jo</creatorcontrib><creatorcontrib>Kato, Kenichi</creatorcontrib><creatorcontrib>Fukaya, Shusaku</creatorcontrib><creatorcontrib>Yoshida, Shunji</creatorcontrib><title>Stressors and rheumatoid arthritis: changes in stressors with advances in therapeutic agents</title><title>Rheumatology international</title><addtitle>Rheumatol Int</addtitle><addtitle>Rheumatol Int</addtitle><description>The significance of evaluations of stressors in rheumatoid arthritis (RA) patients was investigated from the perspective of holistic medicine. The subjects were RA patients treated in the rheumatology outpatient clinic. They included 30 patients from 1987, 30 from 2002, and 137 from 2009. To investigate the specific causes of stress, the patients were asked the question, “What do you feel is your strongest stressor?” The same patients also underwent psychological testing and was examined the disease activity. Pain was the strongest stressor in RA patients in 1987, 2002, and 2009. However, the percentage of patients citing pain as their major stressor was decreasing with each year. CRP was significantly lower in 2009 than in 2002. CRP was also significantly lower in patients who used biologics than in patients who did not. In 2009, DAS28-CRP was significantly higher in patients whose largest stressor was pain than in patients whose largest stressor was another factor. In 2009, the values for both state anxiety and trait anxiety were significantly higher in patients who said that they had stressors than in those who said they did not. The strongest stressor in RA patients was pain. However, the percentage decreased over the years with lower disease activity from advances in therapeutic agents such as biologics. Meanwhile, stressors other than pain were the same or somewhat increased, and they were related to anxiety or depression. Understanding stressors in RA is thus important in treating RA patients.</description><subject>Adult</subject><subject>Aged</subject><subject>Antirheumatic Agents - therapeutic use</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Arthritis, Rheumatoid - psychology</subject><subject>Biological Products - therapeutic use</subject><subject>Female</subject><subject>Health Status</subject><subject>Humans</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Original Article</subject><subject>Pain - drug therapy</subject><subject>Pain - psychology</subject><subject>Pain Measurement</subject><subject>Rheumatology</subject><subject>Severity of Illness Index</subject><subject>Stress, Psychological - psychology</subject><issn>0172-8172</issn><issn>1437-160X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kE1LxDAURYMozjj6A9xIwXX05aNJ404Gv2DAhQouhJCm6bTitGOSKv57M3QUN27yCO-8e-EgdEzgjADI8wBAlcBAKKY8l1jsoCnhTGIi4HkXTYFIiov0TNBBCK-Q_kLAPppQWhAuFZ2il4foXQi9D5npqsw3bliZ2LdVZnxsfBvbcJHZxnRLF7K2y8Iv_tnGJjPVh-nsuIqN82bthtjazCxdF8Mh2qvNW3BH2zlDT9dXj_NbvLi_uZtfLrBlkkZcFAxUXuY1gJJQmDQJ5U6JUrG8AOlYUdbAFLW14ZJaXlvLiCzyKq8UlSWbodMxd-3798GFqF_7wXepUhNGaa5AcJ4oMlLW9yF4V-u1b1fGf2kCeuNTjz51atcbn1qkm5Nt8lCuXPV78SMwAXQEQlolSf5P9b-p35GLgHA</recordid><startdate>20130401</startdate><enddate>20130401</enddate><creator>Otake, Tomoko</creator><creator>Ashihara, Mutsumi</creator><creator>Nishino, Jo</creator><creator>Kato, Kenichi</creator><creator>Fukaya, Shusaku</creator><creator>Yoshida, Shunji</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20130401</creationdate><title>Stressors and rheumatoid arthritis: changes in stressors with advances in therapeutic agents</title><author>Otake, Tomoko ; Ashihara, Mutsumi ; Nishino, Jo ; Kato, Kenichi ; Fukaya, Shusaku ; Yoshida, Shunji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-883095b5f009708af00124e96b935807e38bf0392cfa472c4fcc31785d5d927b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antirheumatic Agents - therapeutic use</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Arthritis, Rheumatoid - psychology</topic><topic>Biological Products - therapeutic use</topic><topic>Female</topic><topic>Health Status</topic><topic>Humans</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Original Article</topic><topic>Pain - drug therapy</topic><topic>Pain - psychology</topic><topic>Pain Measurement</topic><topic>Rheumatology</topic><topic>Severity of Illness Index</topic><topic>Stress, Psychological - psychology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Otake, Tomoko</creatorcontrib><creatorcontrib>Ashihara, Mutsumi</creatorcontrib><creatorcontrib>Nishino, Jo</creatorcontrib><creatorcontrib>Kato, Kenichi</creatorcontrib><creatorcontrib>Fukaya, Shusaku</creatorcontrib><creatorcontrib>Yoshida, Shunji</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Rheumatology international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Otake, Tomoko</au><au>Ashihara, Mutsumi</au><au>Nishino, Jo</au><au>Kato, Kenichi</au><au>Fukaya, Shusaku</au><au>Yoshida, Shunji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stressors and rheumatoid arthritis: changes in stressors with advances in therapeutic agents</atitle><jtitle>Rheumatology international</jtitle><stitle>Rheumatol Int</stitle><addtitle>Rheumatol Int</addtitle><date>2013-04-01</date><risdate>2013</risdate><volume>33</volume><issue>4</issue><spage>887</spage><epage>891</epage><pages>887-891</pages><issn>0172-8172</issn><eissn>1437-160X</eissn><abstract>The significance of evaluations of stressors in rheumatoid arthritis (RA) patients was investigated from the perspective of holistic medicine. The subjects were RA patients treated in the rheumatology outpatient clinic. They included 30 patients from 1987, 30 from 2002, and 137 from 2009. To investigate the specific causes of stress, the patients were asked the question, “What do you feel is your strongest stressor?” The same patients also underwent psychological testing and was examined the disease activity. Pain was the strongest stressor in RA patients in 1987, 2002, and 2009. However, the percentage of patients citing pain as their major stressor was decreasing with each year. CRP was significantly lower in 2009 than in 2002. CRP was also significantly lower in patients who used biologics than in patients who did not. In 2009, DAS28-CRP was significantly higher in patients whose largest stressor was pain than in patients whose largest stressor was another factor. In 2009, the values for both state anxiety and trait anxiety were significantly higher in patients who said that they had stressors than in those who said they did not. The strongest stressor in RA patients was pain. However, the percentage decreased over the years with lower disease activity from advances in therapeutic agents such as biologics. Meanwhile, stressors other than pain were the same or somewhat increased, and they were related to anxiety or depression. Understanding stressors in RA is thus important in treating RA patients.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>22814792</pmid><doi>10.1007/s00296-012-2457-6</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0172-8172 |
ispartof | Rheumatology international, 2013-04, Vol.33 (4), p.887-891 |
issn | 0172-8172 1437-160X |
language | eng |
recordid | cdi_proquest_journals_1322590644 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Adult Aged Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - drug therapy Arthritis, Rheumatoid - psychology Biological Products - therapeutic use Female Health Status Humans Male Medicine Medicine & Public Health Middle Aged Original Article Pain - drug therapy Pain - psychology Pain Measurement Rheumatology Severity of Illness Index Stress, Psychological - psychology |
title | Stressors and rheumatoid arthritis: changes in stressors with advances in therapeutic agents |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T22%3A43%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stressors%20and%20rheumatoid%20arthritis:%20changes%20in%20stressors%20with%20advances%20in%20therapeutic%20agents&rft.jtitle=Rheumatology%20international&rft.au=Otake,%20Tomoko&rft.date=2013-04-01&rft.volume=33&rft.issue=4&rft.spage=887&rft.epage=891&rft.pages=887-891&rft.issn=0172-8172&rft.eissn=1437-160X&rft_id=info:doi/10.1007/s00296-012-2457-6&rft_dat=%3Cproquest_cross%3E2933707511%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1322590644&rft_id=info:pmid/22814792&rfr_iscdi=true |